Eye Cancer Caused by 2 Gene Mutations

At the University of California, San Diego School of Medicine, researchers have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug. The findings are published online in the May 29 issue of the journal emCancer Cell/em. "The beauty of our study is its simplicity," said Kun-Liang Guan, ...